甲烯化物 甲烯化物

Same author

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Same author

Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Same author

Enhanced patient selection with quantitative continuous scoring of PD-L1 expression for IO treatment in metastatic NSCLC.

NPJ precision oncology·2025

Same author

Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Same author

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.

Oncoimmunology·2019

Same author

Rare-Variant Studies to Complement Genome-Wide Association Studies.

Annual review of genomics and human genetics·2018

Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026

Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026

Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026

Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026

Same journal

Retraction.

Science (New York, N.Y.)·2026

Same journal

Making time.

Science (New York, N.Y.)·2026

相关实验视频

甲烯化物甲烯化物

相关概念视频

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.

Enhanced patient selection with quantitative continuous scoring of PD-L1 expression for IO treatment in metastatic NSCLC.

Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.

Rare-Variant Studies to Complement Genome-Wide Association Studies.

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Local signals, systemic decline.

The mechanics of liver regeneration.

Computing in a memory with physics.

Retraction.

Making time.

相关实验视频

甲烯化物 甲烯化物

相关概念视频

相关文章

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.

Enhanced patient selection with quantitative continuous scoring of PD-L1 expression for IO treatment in metastatic NSCLC.

Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.

Rare-Variant Studies to Complement Genome-Wide Association Studies.

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Local signals, systemic decline.

The mechanics of liver regeneration.

Computing in a memory with physics.

Retraction.

Making time.

甲烯化物甲烯化物